Browsing: Rating

Salesforce (NYSE:CRM – Get Free Report)’s stock had its “market outperform” rating reiterated by equities research analysts at Citizens Jmp in a report released on Friday, Benzinga reports. They presently have a $315.00 target price on the CRM provider’s stock. Citizens Jmp’s target price points to a potential upside of 29.44% from the company’s current…

Salesforce (NYSE:CRM – Get Free Report)’s stock had its “equal weight” rating reaffirmed by investment analysts at Stephens in a report released on Friday, Benzinga reports. They currently have a $289.00 target price on the CRM provider’s stock. Stephens’ price target indicates a potential upside of 18.76% from the company’s previous close.

Salesforce (NYSE:CRM – Get Free Report)’s stock had its “overweight” rating reiterated by research analysts at Cantor Fitzgerald in a note issued to investors on Thursday, Benzinga reports. They presently have a $300.00 price objective on the CRM provider’s stock. Cantor Fitzgerald’s price target suggests a potential upside of 19.70% from the stock’s current price.

Salesforce (NYSE:CRM – Get Free Report)’s stock had its “buy” rating reissued by investment analysts at Needham & Company LLC in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $400.00 target price on the CRM provider’s stock. Needham & Company LLC’s price objective points to a potential upside of…

The rating engine, long the preserve of actuaries, is becoming a strategic tool for a much wider group of insurance teams. Marketing, innovation and product functions are increasingly looking to pricing technology to launch offers faster, adapt campaigns and respond to changing customer expectations.

Salesforce (NYSE:CRM – Get Free Report)’s stock had its “buy” rating reaffirmed by investment analysts at BTIG Research in a research note issued on Wednesday, Benzinga reports. They presently have a $300.00 price target on the CRM provider’s stock. BTIG Research’s price target would suggest a potential upside of 16.28% from the stock’s current price.

Salesforce (NYSE:CRM – Get Free Report)’s stock had its “buy” rating restated by Needham & Company LLC in a note issued to investors on Thursday,Benzinga reports. They currently have a $400.00 price objective on the CRM provider’s stock. Needham & Company LLC’s target price suggests a potential upside of 94.17% from the company’s previous close.